Purification of a low molecular weight fucoidan for SPECT molecular imaging of myocardial infarction

Mar Drugs. 2014 Sep 23;12(9):4851-67. doi: 10.3390/md12094851.

Abstract

Fucoidans constitute a large family of sulfated polysaccharides with several biochemical properties. A commercial fucoidan from brown algae, containing low molecular weight polysaccharidic species constituted of l-fucose, uronic acids and sulfate groups, was simply treated here with calcium acetate solution. This treatment led to a purified fraction with a yield of 45%. The physicochemical characterizations of the purified fucoidan using colorimetric assay, MALLS, dRI, FT-IR, NMR, exhibited molecular weight distributions and chemical profiles similar for both fucoidans whereas the sulfate and l-fucose contents increased by 16% and 71%, respectively. The biodistribution study in rat of both compounds labeled with 99mTc evidenced a predominant renal elimination of the purified fucoidan, but the crude fucoidan was mainly retained in liver and spleen. In rat myocardial ischemia-reperfusion, we then demonstrated the better efficiency of the purified fucoidan. This purified sulfated polysaccharide appears promising for the development of molecular imaging in acute coronary syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fucose / analysis
  • Glucuronic Acid / analysis
  • Isotope Labeling
  • Male
  • Molecular Weight
  • Myocardial Infarction / diagnostic imaging*
  • Myocardial Reperfusion Injury / diagnostic imaging
  • Polysaccharides / chemistry
  • Polysaccharides / isolation & purification*
  • Polysaccharides / pharmacokinetics
  • Radiopharmaceuticals / isolation & purification*
  • Radiopharmaceuticals / pharmacokinetics
  • Rats
  • Rats, Wistar
  • Technetium
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon / methods*

Substances

  • Polysaccharides
  • Radiopharmaceuticals
  • Fucose
  • Technetium
  • Glucuronic Acid
  • fucoidan